Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1640.59 (Glytoucan)

Id:a69e6ae8-ecc3-5e84-927c-2645732a2659

Glytoucan:G77466MH

Results found

Linked to

	Label	Description
	1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G52877MJ-GLYCOSEQ00097292 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G30901GC-GLYCOSEQ00115923 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G80563TH-GLYCOSEQ00180561 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G42711TE-GLYCOSEQ00083497 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G23572BH-GLYCOSEQ00096668 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G43981TB-GLYCOSEQ00048013 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G07627PO-GLYCOSEQ00021248 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000007 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G77466MH-GLYCOSEQ00202012 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1640.59 has motif Type 2 LN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G52877MJ-GLYCOSEQ00097292 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G30901GC-GLYCOSEQ00115923 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G80563TH-GLYCOSEQ00180561 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G42711TE-GLYCOSEQ00083497 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G23572BH-GLYCOSEQ00096668 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G43981TB-GLYCOSEQ00048013 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G07627PO-GLYCOSEQ00021248 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000007 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has glycosequence GLYGEN.GLYCOSEQUENCE:G77466MH-GLYCOSEQ00202012 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1640.59 has motif Type 2 LN

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.